glycopyrrolate
Generic: glycopyrrolate
Labeler: somerset therapeutics, llcDrug Facts
Product Profile
Brand Name
glycopyrrolate
Generic Name
glycopyrrolate
Labeler
somerset therapeutics, llc
Dosage Form
SOLUTION
Routes
Active Ingredients
glycopyrrolate .2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70069-617
Product ID
70069-617_2fc11e36-103a-4967-9130-89ab02d9a1f0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207639
Listing Expiration
2026-12-31
Marketing Start
2024-07-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70069617
Hyphenated Format
70069-617
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
glycopyrrolate (source: ndc)
Generic Name
glycopyrrolate (source: ndc)
Application Number
ANDA207639 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .2 mg/mL
Packaging
- 25 VIAL in 1 CARTON (70069-617-25) / 1 mL in 1 VIAL (70069-617-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "2fc11e36-103a-4967-9130-89ab02d9a1f0", "openfda": {"upc": ["0370069616017", "0370069619018", "0370069617014", "0370069618257", "0370069617250", "0370069618011", "0370069619254", "0370069616109"], "unii": ["V92SO9WP2I"], "rxcui": ["238212", "1731582", "1731590"], "spl_set_id": ["48cfbd5a-b133-4720-9bd7-65296064ea3c"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (70069-617-25) / 1 mL in 1 VIAL (70069-617-01)", "package_ndc": "70069-617-25", "marketing_start_date": "20240731"}], "brand_name": "GLYCOPYRROLATE", "product_id": "70069-617_2fc11e36-103a-4967-9130-89ab02d9a1f0", "dosage_form": "SOLUTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "70069-617", "generic_name": "GLYCOPYRROLATE", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA207639", "marketing_category": "ANDA", "marketing_start_date": "20240731", "listing_expiration_date": "20261231"}